Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy

- Lipidic in-situ nanoemulsifying formulation of resveratrol.
- Improvement in solubility and therapeutic efficacy of resveratrol.
- Enhanced cytotoxicity in MCF-7 breast cancer cells.
- Enhanced antiangiogenic effect in chick chorioallantoic membrane assay.
- A potential and safe therapeutic delivery system for cancer chemoprevention.